Kroger Recalls Imatinib Mesylate Tablets Due to Lack of Processing Controls
Kroger Specialty Pharmacy is recalling one lot of Imatinib Mesylate 400 mg tablets because the product lacked required processing controls.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The FDA classified this as a Class II recall due to a lack of processing controls, which presents a risk of harm where injury has not yet been reported. Per the rubric, this aligns with the High severity criteria for risk-of-harm products without reported illness.
Plain-English summary
Kroger Specialty Pharmacy, Inc. has initiated a voluntary recall of Imatinib Mesylate Tablet 400 mg (NDC 60505-2901-03). The recall affects all lots remaining within their expiry date that were dispensed between December 1, 2017, and February 12, 2018. The product was distributed in Mississippi, Louisiana, Arkansas, Illinois, and Florida.
The U.S. Food and Drug Administration (FDA) classified this recall as Class II. The reason for the recall is a lack of processing controls during manufacturing. This defect could potentially affect the quality or safety of the medication, although no illnesses or injuries have been reported at this time.
Consumers who may have received this product should contact Kroger Specialty Pharmacy immediately to return the tablets or obtain a replacement. Healthcare providers and patients are advised to check lot numbers against the recall information provided by the FDA.
The recalled product
- Product
- Imatinib Mesylate Tablet 400 mg NDC 60505-2901-03 30 days supply
- Manufacturer
- Kroger Specialty Pharmacy, Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018
Distribution
Part of a larger recall action
This product is one of 67 recalled by Kroger Specialty Pharmacy, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 67 products in this recall →Related recalls
Same manufacturer · Kroger Specialty Pharmacy, Inc.
See all →- HighKroger Recalls Botox Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- HighKroger Recalls Capecitabine Tablets Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- ModerateKroger Specialty Pharmacy Recalls Cimzia 200 mg/mL PFS Kits
FDA (Drugs) · 2018-05-16
- HighKroger Recalls Lupron Depot Due to Lack of Processing Controls
FDA (Drugs) · 2018-05-16
- ModerateKroger Specialty Pharmacy Recalls Cyclophosphamide Capsules Due to Processing Controls
FDA (Drugs) · 2018-05-16
Same hazard · lack of processing controls
See all →- ModerateMasterPharm Recalls Vardenafil Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Yohimbine HCL Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05